Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: ISOLA THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2023-07-12 to 2025-07-11
Current total value of award: $749999
Description: R&D FOR ENDOBRONCHIAL LAVAGE (EBL) TO PREVENT AND TREAT LUNG DAMAGE FROM PULMONARY CHEMICAL AGENTS AOI #15: REDIRECT (REPURPOSING DRUGS IN RESPONSE TO CHEMICAL THREATS)